Drawing for ALLO VIR

USPTO serial 97799503

ALLO VIR

Reviewed by CopyMark Law Group

Reg. 7396297Status 700Registered
Filing date
Status date
Registration date
May 28, 2024
Examiner
REGAN, JOHN B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALLO VIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER, PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; antiviral allogeneic cell therapy products in the nature of T cells; antiviral allogeneic cell therapy products in the nature of virus-specific T cells; antiviral cells for medical use; antiviral T cells for medical use; antiviral virus-specific T cells for medical use; antiviral immunotherapeutic agents for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, allogenic T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely, virus-specific T cells, for restoring viral immunity in immunocompromised patientsACTIVEOct 31, 2023
042Research and development in the pharmaceutical and biotechnology fieldsACTIVEOct 31, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 28, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jan 9, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 9, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 9, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2023AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Nov 28, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2023IUAAUSE AMENDMENT ACCEPTED—
Nov 16, 2023DOCKASSIGNED TO EXAMINER—
Nov 9, 2023AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Nov 9, 2023IUAFUSE AMENDMENT FILED—
Nov 7, 2023EAAUTEAS AMENDMENT OF USE RECEIVED—
Mar 23, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 23, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 8, 2023MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 21, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance